Should we proceed with a total abdominal hysterectomy in a patient with a markedly elevated eosinophil count (16%)?

Do Not Proceed with Total Abdominal Hysterectomy Until Eosinophilia is Fully Evaluated and Underlying Cause Identified

An eosinophil count of 16% represents significant peripheral eosinophilia that requires immediate investigation before any elective surgery, including total abdominal hysterectomy, to prevent potentially life-threatening perioperative complications and to identify serious underlying systemic conditions.

Critical Context: Why This Matters

An eosinophil percentage of 16% translates to marked peripheral eosinophilia (likely absolute eosinophil count >1500 cells/µL, depending on total white blood cell count). This degree of elevation is not a benign finding and demands systematic evaluation before proceeding with elective surgery.

Immediate Concerns

Hypereosinophilic Syndrome (HES) must be ruled out first. HES is defined as absolute eosinophil count >1500 cells/µL with organ/tissue damage due to eosinophilic infiltration 1. Up to 38% of HES patients have gastrointestinal symptoms, but critically, HES can cause:

• Cardiac involvement (endomyocardial fibrosis, myocarditis, heart failure)
• Neurologic complications (encephalopathy, neuropathy)
• Pulmonary disease
• Thrombotic events

Any of these would dramatically increase surgical morbidity and mortality.

Differential Diagnosis Algorithm

The eosinophilia must be categorized systematically:

1. Primary (Clonal/Neoplastic) Eosinophilia 2:

• Myeloid/lymphoid neoplasms with eosinophilia (PDGFRA, PDGFRB, FGFR1 rearrangements)
• Chronic eosinophilic leukemia
• Myeloproliferative neoplasms
• These require hematology referral and may contraindicate surgery entirely until treated

2. Secondary (Reactive) Eosinophilia 1:

• Parasitic infections (strongyloidiasis, schistosomiasis, filariasis, toxocariasis) - critical to exclude before any immunosuppression or surgery 3, 4
• Drug reactions - review all medications
• Eosinophilic granulomatosis with polyangiitis (EGPA/Churg-Strauss) - systemic vasculitis with multi-organ involvement 1
• Allergic conditions (asthma, atopic disease) - though typically cause milder eosinophilia 5
• Eosinophilic gastrointestinal disorders (eosinophilic esophagitis, gastritis, enteritis) 1, 6, 7

3. Idiopathic Hypereosinophilic Syndrome:

• Diagnosis of exclusion after comprehensive workup

Mandatory Pre-Operative Evaluation

Before scheduling hysterectomy, the following must be completed:

Laboratory Assessment

• Absolute eosinophil count calculation (not just percentage)
• Complete blood count with differential (repeat to confirm persistence)
• Peripheral blood smear review
• Serum tryptase, vitamin B12 (elevated in myeloproliferative disorders)
• Troponin, NT-proBNP (cardiac involvement screening) 2
• IgE levels
• ANCA testing (for EGPA) 1

Imaging and Functional Studies

• Echocardiogram - mandatory to assess for cardiac involvement 2
• Chest X-ray or CT chest (pulmonary infiltrates, asthma)
• ECG (conduction abnormalities from cardiac infiltration)

Specialist Consultations

• Hematology referral - essential for eosinophilia >1.5 × 10⁹/L 8
  • Consider bone marrow biopsy with cytogenetics and molecular testing for PDGFRA/PDGFRB/FGFR1 rearrangements 2
• Infectious disease consultation - parasitic serologies and stool examinations 3, 4
  • Strongyloides serology is critical (hyperinfection syndrome risk with surgery/stress)
  • Consider tropical travel history
• Allergy/immunology if atopic features present 5
• Cardiology if any cardiac symptoms or abnormal troponin/BNP 2

Specific Perioperative Risks with Uncontrolled Eosinophilia

1. Cardiac complications: Eosinophil-mediated myocardial damage can cause perioperative heart failure, arrhythmias, or sudden death
2. Thrombotic events: Hypereosinophilia increases thrombosis risk
3. Strongyloides hyperinfection: If parasitic infection present, surgical stress can trigger fatal disseminated strongyloidiasis
4. Delayed wound healing: Eosinophil granule proteins can impair tissue repair
5. Anesthetic complications: Increased risk with cardiac or pulmonary involvement

Clinical Decision Pathway

If eosinophilia is due to:

• Myeloproliferative neoplasm with PDGFRA/PDGFRB rearrangement: Start imatinib 100-400 mg daily, achieve hematologic remission, then reassess surgical candidacy 2

• Parasitic infection: Treat appropriately (albendazole, ivermectin, praziquantel depending on organism), document clearance, then proceed 3, 4

• EGPA or systemic vasculitis: Requires immunosuppression and rheumatology management; surgery only after disease control 1

• Drug reaction: Discontinue offending agent, document resolution, then proceed

• Idiopathic HES with organ involvement: May require corticosteroids ± cytoreductive therapy before surgery; cardiology clearance mandatory 1, 2, 1

When Surgery Can Proceed

Surgery should only be scheduled after:

1. Absolute eosinophil count normalized or adequately controlled (<1.5 × 10⁹/L preferred)
2. Underlying cause identified and treated
3. No evidence of end-organ damage (especially cardiac)
4. Hematology clearance obtained
5. Parasitic infections definitively excluded or treated

Common Pitfalls to Avoid

• Do not dismiss eosinophilia as "just allergies" - 16% is too high for simple atopy
• Do not proceed with "routine" preoperative clearance - this requires specialized evaluation
• Do not start corticosteroids empirically before excluding strongyloidiasis (risk of hyperinfection) 4
• Do not assume eosinophilia will resolve post-operatively - it indicates systemic disease
• Do not delay cardiac evaluation - eosinophil-mediated cardiac damage is irreversible if missed

Bottom Line

Postpone the hysterectomy. The gynecologic indication for surgery (presumably benign uterine pathology based on context) can wait while life-threatening causes of marked eosinophilia are systematically excluded. The morbidity and mortality risks of operating on a patient with undiagnosed HES, cardiac involvement, or occult parasitic infection far outweigh any benefit of proceeding with elective surgery. Recent evidence suggests that even eosinophil counts approaching 1.0 × 10⁹/L confer maximally increased risks of hematological malignancy 9, and a threshold of 1.5 × 10⁹/L warrants hematology referral 8.

While minimally invasive hysterectomy approaches are generally preferred for benign disease 10, 11, the route of surgery is irrelevant if the patient has uncontrolled systemic eosinophilia with potential cardiac, thrombotic, or infectious complications that could prove fatal perioperatively.